查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715697

生物影像市场（按技术、产品、模式、应用和最终用户划分）—2025-2030 年全球预测

Bio-imaging Market by Technology, Product, Modality, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年生物成像市场价值将达67亿美元，2025年将达73.8亿美元，复合年增长率为10.23%，到2030年将达到120.3亿美元。

主要市场统计数据
基准年2024年 67亿美元
预计2025年 73.8亿美元
预测年份 2030 120.3亿美元
复合年增长率（%） 10.23%

生物影像是医学创新的核心，它提供了强大的工具，改变了临床医生和研究人员观察内部生命结构的方式。在当今快速发展的科学环境中，影像技术对于诊断、治疗计划和突破性研究至关重要。感测器技术、数据处理和影像处理软体的最新进展使得疾病检测和监测更加准确，代表了临床和研究领域的重大突破。

工程能力与生物学洞察力的结合为创新成像解决方案铺平了道路，这些解决方案不仅提高了诊断的准确性，还降低了侵入性。随着成像系统变得越来越复杂，最终使用者能够更有自信、准确地做出决策。本介绍深入探讨了决定生物成像领域发展轨迹的变革、细分因素、区域动态和竞争格局。

在探索这些方面，很明显该领域并不是孤立地发展，而是正在迅速整合跨学科创新以解决医疗保健领域长期存在的挑战。在数据驱动和创新的推动下，生物成像透过将传统诊断方法与现代技术突破相结合，不断扩大其影响力，最终重塑我们对待患者照护和生物医学研究的方式。

重塑生物影像领域的变革

随着技术突破与新的临床要求的融合，生物成像领域正在发生巨大的变化。这种转变的特点是融合了多种创新，扩大了能力，提高了精确度，并降低了操作复杂性。人工智慧、先进计算技术和自动化在诊断成像领域的快速融合，不仅加快了影像撷取和分析的速度，而且提高了各种应用所需的解释准确性。

最显着的变化之一是混合成像系统的出现，该系统融合了不同的显像模式，提供对生物过程的全面观察。在强大的数据分析的支持下，这些系统为临床医生提供了检测细微异常的无与伦比的准确性。硬体小型化和感测器灵敏度提高的最新进展使得人们能够获得更清晰、更详细的影像，极大地促进了疾病的早期发现和精准的治疗性介入。

此外，影像处理软体的进步重新定义了医生如何管理大型资料集和提取可操作的见解。现在，复杂的演算法和增强的影像分析工具可以对异常进行详细量化，并追踪疾病随时间的进展。随着这些变革性转变不断重新定义产业动态，相关人员被鼓励接受创新，以在快速发展的市场中保持竞争力。

生物成像的全面分割洞察

生物成像市场复杂且细分，反映了推动这一动态领域的技术、产品、模式、应用和最终用户的多样性。从技术方面考虑，调查通常涉及多种成像模式。市场研究涉及内视镜、磁振造影、核子医学摄影、手术显微镜、超音波和X光成像等先进领域。这种技术细分提供了对每种方式如何促进诊断准确性的细緻理解，并可以指南有针对性的创新。

同时，产品细分已扩展到成像系统、仪器、试剂和软体等不同类别。在设备类别中，特别关注 CT 扫描仪、 核磁共振造影系统和超音波诊断设备，强调这些技术在现代医学诊断中发挥的重要作用。同样，软体部门分为资料管理系统和影像分析工具，两者都有助于处理和解释复杂的影像资料。

此外，基于模态的分割区分了 2D 和 3D 成像，为实现更具身临其境型的诊断和治疗技术提供了启示。应用领域涵盖临床诊断、药物发现、研究和治疗等广泛领域，突显了生物影像在临床和实验环境中的多方面应用。最后，报告重点关注最终用户，从门诊手术中心到诊断影像中心，以及医院和诊所。每个细分市场都提供了生物成像市场的详细全景，并为相关人员提供了发展趋势、投资前景和技术创新机会的见解。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性疾病和神经系统疾病盛行率不断上升
      • 全球转向非侵入性诊断
      • 医疗成本和医疗基础设施投资不断增加
    • 限制因素
      • 生物成像设备和系统的严格监管标准和互通性问题
    • 机会
      • 开发适用于照护现场的可携式、价格实惠的生物成像设备
      • 扩大神经病学和肿瘤学中的生物成像应用
    • 任务
      • 与使用生物成像数据有关的伦理和隐私问题
  • 市场区隔分析
    • 技术：超音波因其价格实惠和非电离特性而越来越受到青睐
    • 最终用户：诊断成像中心扩大生物成像的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 生物影像市场（按技术）

  • 内视镜检查
  • 磁振造影
  • 核子造影
  • 手术显微镜
  • 超音波
  • X光影像

第七章生物影像市场（按产品）

  • 影像系统
  • 装置
    • CT扫描仪
    • 核磁共振造影系统
    • 超音波设备
  • 试剂
  • 软体
    • 资料管理软体
    • 影像分析软体

第 8 章 生物造影市场（按模式）

  • 二维成像
  • 3D成像

第九章生物成像市场（按应用）

  • 临床诊断
  • 药物研发
  • 调查
  • 治疗

第 10 章 生物影像市场（依最终使用者）

  • 门诊手术中心
  • 诊断影像中心
  • 医院和诊所

第 11 章：美洲生物成像市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12.亚太地区生物成像市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 13 章欧洲、中东和非洲生物成像市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • BaySpec, Inc.
  • Bracco SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Digirad Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Medical Corporation
  • HT BioImaging Ltd
  • iThera Medical GmbH
  • Kitware, Inc.
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • M Squared Lasers Ltd.
  • MARS Bioimaging Limited
  • Medtronic PLC
  • MobileODT Ltd by Liger Medical LLC
  • Perspectum Ltd.
  • Quibim, SL
  • RadNet, Inc.
  • Rivanna Medical, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market was valued at USD 6.70 billion in 2024 and is projected to grow to USD 7.38 billion in 2025, with a CAGR of 10.23%, reaching USD 12.03 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.70 billion
Estimated Year [2025] USD 7.38 billion
Forecast Year [2030] USD 12.03 billion
CAGR (%) 10.23%

Bio-imaging is at the nexus of medical innovation, providing powerful tools that have transformed the way clinicians and researchers visualize internal biological structures. In today's fast-evolving scientific environment, imaging technologies are integral to diagnosis, treatment planning, and breakthrough research. Recent advances in sensor technology, data processing, and imaging software have elevated the precision of disease detection and monitoring, marking a significant leap forward in both clinical and research settings.

The convergence of engineering prowess with biological insights has paved the way for innovative imaging solutions that not only improve diagnostic accuracy but also reduce invasiveness. As imaging systems become more sophisticated, they empower end-users to make decisions with greater confidence and accuracy. This initial introduction sets the stage for a deep dive into the transformative shifts, segmentation factors, regional dynamics, and competitive landscape that are defining the trajectory of the bio-imaging arena.

As we explore these facets, it becomes evident that the sector is not merely evolving in isolation; it is rapidly integrating cross-disciplinary innovations to address longstanding challenges in healthcare. Grounded in data and driven by innovation, bio-imaging continues to expand its influence by merging traditional diagnostic practices with modern technological breakthroughs, ultimately reshaping the way we approach patient care and biomedical research.

Transformative Shifts Reshaping the Bio-Imaging Sector

The landscape of bio-imaging is undergoing dramatic transformation as technological breakthroughs converge with new clinical requirements. This transformation is characterized by an amalgamation of innovations that expand capabilities, refine accuracy, and reduce operational complexity. The rapid integration of artificial intelligence, advanced computing techniques, and automation in imaging has not only accelerated the pace at which images are acquired and analyzed but has also enhanced the interpretative accuracy required for a wide variety of applications.

One of the most notable shifts is the emergence of hybrid imaging systems that merge different imaging modalities to provide comprehensive views of biological processes. These systems, supported by robust data analytics, offer clinicians unparalleled precision in detecting subtle anomalies. Recent improvements in hardware miniaturization and sensor sensitivity allow for clearer, more detailed images that contribute significantly to early disease detection and nuanced therapeutic interventions.

Furthermore, the evolution within imaging software has redefined how practitioners manage large datasets and extract actionable insights. Refined algorithms and enhanced image analysis tools enable the detailed quantification of abnormalities and the tracking of disease progression over time. As these transformative shifts continue to redefine industry dynamics, stakeholders are encouraged to embrace innovation to maintain their competitive edge in a rapidly evolving market.

Comprehensive Segmentation Insights in Bio-Imaging

The bio-imaging market is intricately segmented, reflecting the diversity of technologies, products, modalities, applications, and end users that drive this dynamic field. When considering technological aspects, research regularly spans across multiple imaging methods. The market is studied across advanced areas such as endoscopy, magnetic resonance imaging, nuclear imaging, surgical microscopy, ultrasound, and x-ray imaging. This technological segmentation provides a nuanced understanding of how each modality contributes to diagnostic precision and guides targeted innovation.

In parallel, the product segmentation extends into distinct categories such as imaging systems, instruments, reagents, and software. Within the instruments category, particular attention is given to CT scanners, MRI machines, and ultrasound devices, all of which underscore the pivotal role these technologies play in modern medical diagnostics. Similarly, the software segment is bifurcated into data management systems and image analysis tools, both of which are instrumental in processing and interpreting complex imaging data.

Furthermore, segmentation based on modality distinguishes between 2D imaging and 3D imaging, shedding light on the transition towards more immersive diagnostic and therapeutic techniques. Within the application domain, the market examines a wide spectrum that includes clinical diagnostics, drug discovery, research, and therapeutics, highlighting the multifaceted applications of bio-imaging in both clinical and experimental settings. Lastly, a keen focus is placed on the end users, which range from ambulatory surgical centers to diagnostic imaging centers, and extend into hospitals and clinics. Each segmentation component contributes collectively to a detailed panorama of the bio-imaging market, offering insights into evolution trends, investment prospects, and innovation opportunities for stakeholders.

Based on Technology, market is studied across Endoscopy, Magnetic Resonance Imaging, Nuclear Imaging, Surgical Microscopy, Ultrasound, and X-ray Imaging.

Based on Product, market is studied across Imaging Systems, Instruments, Reagents, and Software. The Instruments is further studied across CT Scanners, MRI Machines, and Ultrasound Devices. The Software is further studied across Data Management Software and Image Analysis Software.

Based on Modality, market is studied across 2D Imaging and 3D Imaging.

Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Research, and Therapeutics.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.

Strategic Regional Insights in Global Bio-Imaging Markets

The evolution of bio-imaging is not just a product of technological advance; it is also shaped by regional dynamics that influence investment, market penetration, and regulatory frameworks. A thorough exploration of the market reveals distinctive trends across major regions. In the Americas, robust healthcare infrastructure coupled with aggressive adoption of advanced technologies fosters an environment ripe for innovation. This region benefits from substantial research investments and a strong network of academic institutions that often pioneer breakthroughs in imaging technology.

Transitioning to regions that encompass Europe, the Middle East, and Africa, the focus is on a blend of longstanding medical expertise and emerging markets. These regions offer a strategic balance where established healthcare systems merge with the need for innovation-driven growth. Regulatory frameworks in these regions are evolving, thus creating pathways for novel imaging modalities to integrate seamlessly with traditional practices while ensuring compliance and patient safety.

In the Asia-Pacific region, rapid urbanization, increased healthcare spending, and expanding medical infrastructure position it as a lucrative market for bio-imaging innovations. The region is experiencing swift technological adoption and a reimagining of traditional diagnostic practices, which leads to enhanced service delivery and competitive advancements. The interplay of these regional insights not only informs localized strategies but also provides a broader understanding of the global momentum driving the bio-imaging industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape: Key Companies Driving Innovation

A competitive analysis of the bio-imaging market reveals a landscape populated by a diverse set of players, each contributing to technological breakthroughs and market expansion. Prominent companies including BaySpec, Inc. and Bracco S.p.A. demonstrate a commitment to quality and innovation that has helped set industry benchmarks. These firms, together with Bruker Corporation and Canon Medical Systems Corporation, are instrumental in pushing the envelope of imaging technologies, ensuring that state-of-the-art systems meet current clinical needs.

Further reinforcing industry dynamism are organizations such as Digirad Corporation, Esaote S.p.A., and Fujifilm Holdings Corporation, which have carved niches in niche areas ranging from advanced imaging systems to specialized reagents. GE HealthCare Technologies, Inc. and Hitachi Medical Corporation continue to be pioneering figures in elevating imaging capabilities with their extensive research and development initiatives. HT BioImaging Ltd and iThera Medical GmbH also showcase their prowess in combining research-grade technologies with practical applications to enhance diagnostic accuracy.

Additional market influencers such as Kitware, Inc., Koninklijke Philips N.V., and Lantheus Medical Imaging, Inc. remain at the forefront of software-driven imaging innovations, complemented by M Squared Lasers Ltd. and MARS Bioimaging Limited, who contribute through precision hardware innovations. Medtronic PLC and MobileODT Ltd by Liger Medical LLC further exemplify the entrepreneurial spirit in this sector, leveraging cutting-edge technology to redefine patient imaging protocols. Industry specialists including Perspectum Ltd., Quibim, S.L., RadNet, Inc., and Rivanna Medical, Inc. maintain high standards in imaging performance, while Samsung Medison Co., Ltd. and Siemens Healthineers are recognized globally for their comprehensive healthcare solutions. Together, these companies form a robust network of innovators whose contributions are indispensable in driving the bio-imaging field toward a future of enhanced diagnostic and therapeutic performance.

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Digirad Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hitachi Medical Corporation, HT BioImaging Ltd, iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT Ltd by Liger Medical LLC, Perspectum Ltd., Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers. Strategic Recommendations for Navigating the Bio-Imaging Market

Industry leaders are encouraged to adopt a multipronged strategy that emphasizes continued investment in research and development, collaboration across disciplines, and an agile response to regulatory changes. It is imperative that decision-makers harness the potential of advanced analytics and artificial intelligence to process the ever-growing volume of imaging data. By integrating data-driven insights into strategic planning, companies can preemptively address market shifts and tailor their product portfolios to meet evolving clinical needs.

To remain competitive, companies should prioritize partnerships that bridge the gap between engineering innovations and biological applications. Engaging in joint ventures or collaborations with academic institutions and research organizations can facilitate access to cutting-edge technologies and foster a culture of continuous improvement. Furthermore, adopting a global perspective that accounts for regional variances in healthcare infrastructure and regulatory environments will enhance a company's ability to customize solutions to local market demands.

Leaders would also benefit from streamlining operational workflows and investing in digital transformation initiatives that drive efficiency. This includes enhancing cybersecurity protocols and ensuring robust data governance to protect sensitive patient information. Ultimately, a forward-thinking approach that balances innovation with operational excellence will be key to harnessing the full potential of the bio-imaging market.

Conclusion: The Future Landscape of Bio-Imaging

In summary, the trajectory of bio-imaging is steering toward a future that is marked by technological integration, strategic segmentation, and robust regional dynamics. The insights gleaned from advanced imaging systems, segmented analyses across technology, product, modality, application, and end user, display a market that is thriving on innovation and collaboration. Through transformative shifts in both hardware and software capabilities, bio-imaging is not only enhancing clinical outcomes but also paving the way for novel research frontiers.

The ongoing evolution in imaging technology and data analytics promises to unlock new possibilities in precision medicine, thereby shaping the future of healthcare delivery on a global scale. As healthcare providers and innovators continue to navigate a landscape defined by rapid change, the need for astute market analysis and proactive strategic planning becomes increasingly apparent. This conclusion underscores the relevance of staying informed about the latest trends and being prepared to take decisive action in a competitive environment.

Ultimately, by embracing a holistic view that merges innovation with practical application, stakeholders can drive meaningful improvements in patient care and clinical research, ensuring that bio-imaging remains at the forefront of medical advancement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases and neurological disorders
      • 5.1.1.2. Global shift toward non-invasive diagnostic methods
      • 5.1.1.3. Rising healthcare expenditure and investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory standards and interoperability issues of bio-imaging devices and systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of portable and affordable bio-imaging devices for use in point-of-care settings
      • 5.1.3.2. Expansion of bio-imaging applications within the neurology and oncology sectors
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and privacy concerns associated with use of bio-imaging data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for ultrasound due to its affordability and non-ionizing nature
    • 5.2.2. End User: Expanding usage of bio-imaging by diagnostic imaging centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

  • 6.1. Introduction
  • 6.2. Endoscopy
  • 6.3. Magnetic Resonance Imaging
  • 6.4. Nuclear Imaging
  • 6.5. Surgical Microscopy
  • 6.6. Ultrasound
  • 6.7. X-ray Imaging

7. Bio-imaging Market, by Product

  • 7.1. Introduction
  • 7.2. Imaging Systems
  • 7.3. Instruments
    • 7.3.1. CT Scanners
    • 7.3.2. MRI Machines
    • 7.3.3. Ultrasound Devices
  • 7.4. Reagents
  • 7.5. Software
    • 7.5.1. Data Management Software
    • 7.5.2. Image Analysis Software

8. Bio-imaging Market, by Modality

  • 8.1. Introduction
  • 8.2. 2D Imaging
  • 8.3. 3D Imaging

9. Bio-imaging Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery
  • 9.4. Research
  • 9.5. Therapeutics

10. Bio-imaging Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Americas Bio-imaging Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Bio-imaging Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Bio-imaging Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. UCSF and GE HealthCare collaborate to advance bio-imaging innovations in brain health and oncology
    • 14.3.2. Nikon strengthens European bio-imaging capabilities with expansion of BioImaging Labs to boost drug discovery efforts
    • 14.3.3. Strategic partnership between MARS Bioimaging and Linkoping University sets new standards in photon-counting CT technology advancement
    • 14.3.4. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
    • 14.3.5. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BaySpec, Inc.
  • 2. Bracco S.p.A.
  • 3. Bruker Corporation
  • 4. Canon Medical Systems Corporation
  • 5. Digirad Corporation
  • 6. Esaote S.p.A
  • 7. Fujifilm Holdings Corporation
  • 8. GE HealthCare Technologies, Inc.
  • 9. Hitachi Medical Corporation
  • 10. HT BioImaging Ltd
  • 11. iThera Medical GmbH
  • 12. Kitware, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lantheus Medical Imaging, Inc.
  • 15. M Squared Lasers Ltd.
  • 16. MARS Bioimaging Limited
  • 17. Medtronic PLC
  • 18. MobileODT Ltd by Liger Medical LLC
  • 19. Perspectum Ltd.
  • 20. Quibim, S.L.
  • 21. RadNet, Inc.
  • 22. Rivanna Medical, Inc.
  • 23. Samsung Medison Co., Ltd.
  • 24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. BIO-IMAGING MARKET MULTI-CURRENCY
  • FIGURE 2. BIO-IMAGING MARKET MULTI-LANGUAGE
  • FIGURE 3. BIO-IMAGING MARKET RESEARCH PROCESS
  • FIGURE 4. BIO-IMAGING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIO-IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 329. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 330. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024